Employers › Sutro Biopharma
Recordkeeping fees per participant · Remitly, Inc. 401(k) Plan · plan year 2024
$11.91
Higher than 12% of the 5,847 plans $50 to 250M that report it.
= $10,419 / 875
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251106180409NAL0012373777001, received 2025-11-06
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251106180409NAL0012373777001, received 2025-11-06
Percentiles compare this plan with the Schedule H plans $50 to 250M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-11-06.
Administrative expenses excluding investment management, per participant
$62.26
Higher than 31% of the 8,758 plans $50 to 250M that report it.
= $54,481 / 875
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251106180409NAL0012373777001, received 2025-11-06
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251106180409NAL0012373777001, received 2025-11-06
Administrative expenses per participant
$65.27
Higher than 22% of the 9,042 plans $50 to 250M that report it.
= $57,110 / 875
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251106180409NAL0012373777001, received 2025-11-06
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251106180409NAL0012373777001, received 2025-11-06
Administrative expenses as a share of assets
0.100%
Higher than 37% of the 9,049 plans $50 to 250M that report it.
= $57,110 / $57,094,856
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251106180409NAL0012373777001, received 2025-11-06
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251106180409NAL0012373777001, received 2025-11-06
Employer contributions per participant
$2,872
Higher than 53% of the 9,105 plans $50 to 250M that report it.
= $2,513,430 / 875
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251106180409NAL0012373777001, received 2025-11-06
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251106180409NAL0012373777001, received 2025-11-06
Employer share of total contributions
11.9%
Higher than 6% of the 9,112 plans $50 to 250M that report it.
= $2,513,430 / $21,066,946
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251106180409NAL0012373777001, received 2025-11-06
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251106180409NAL0012373777001, received 2025-11-06
Plan terms are described in Sutro Biopharma, Inc.'s SEC filings: Form 10-K filed 2026-03-23. No term could be quoted from them with the required precision.
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 2S pre-approved plan document · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251106180409NAL0012373777001, received 2025-11-06
| Field | Value | Source |
|---|---|---|
| Plan sponsor | REMITLY, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Plan name | REMITLY, INC. 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Sponsor EIN / plan number | 45-2441988 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Sponsor location | SEATTLE, WA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Industry (business code) | 522300, Finance and insurance | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Filing received | 2025-11-06 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Amended filing | yes | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Participants, beginning of year | 801 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Active participants | 792 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Participants, end of year | 906 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Participants with an account balance | 875 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Total assets, beginning of year | $37,331,215 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Total assets, end of year | $57,094,856 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Net assets, end of year | $57,094,856 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Total income | $27,053,030 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Net income | $19,763,641 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Employer contributions | $2,513,430 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Participant contributions | $14,626,106 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Other contributions (incl. rollovers) | $3,927,410 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Total contributions | $21,066,946 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Benefit payments | $7,187,187 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Total expenses (incl. benefit payments) | $7,289,389 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Total administrative expenses | $57,110 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Contract administrator fees | $44,062 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Recordkeeping fees | $10,419 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Investment advisory and management fees | $2,629 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Administrative expenses excluding investment management | $54,481 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Held in mutual funds | $49,606,463 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251106180409NAL0012373777001, received 2025-11-06 |
| Independent auditor | BAKER TILLY | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251106180409NAL0012373777001, received 2025-11-06 |
Position = column in the DOL layout for form year 2024. Filing 20251106180409NAL0012373777001, received 2025-11-06.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| PRINCIPAL LIFE INSURANCE COMPANYrecordkeeper | CONTRACT ADMINISTRATOR | 13 Contract administrator; 37 Participant loan processing; 50 Direct payment from the plan; 64 Recordkeeping fees | $46,454 | yes |
| SCHWAB RETIREMENT PLAN SERVICES,INCrecordkeeper | NONE | 15 Recordkeeping and information management; 26 Investment advisory (participants); 50 Direct payment from the plan; 64 Recordkeeping fees | $10,656 | no |
| CHARLES SCHWAB & CO., INC. | NONE | 33 Securities brokerage; 50 Direct payment from the plan; 62 Float revenue; 71 Securities brokerage commissions and fees; 59 Shareholder servicing fees | $79 | yes |
| MORNINGSTAR INVESTMENT MANAGEMENT | INV ADV, PARTICIPANTS | 26 Investment advisory (participants); 70 Consulting fees | $0 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251106180409NAL0012373777001, received 2025-11-06.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $37,331,215 | $57,094,856 | 52.9% |
| Participants with a balance | 654 | 875 | 33.8% |
| Administrative expenses | $68,895 | $57,110 | -17.1% |
| Recordkeeping fees per participant | not reported | $11.91 | |
| Employer contributions | $562,653 | $2,513,430 | 346.7% |
Prior filing 20241010171012NAL0021496945001, received 2024-10-10; the plan years are contiguous.
Sponsor name as filed: REMITLY, INC.; SEC registrant: SUTRO BIOPHARMA, INC. (CIK 1382101, matched by EIN; display name from the Form 10-K cover).